The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.
More collaborative initiatives are taking place among regulatory agencies, health technology assessment (HTA) bodies and ...
Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...
Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...
Typically, diagnosis of epilepsy begins with a clinical evaluation ... epilepsy treatment Advances in epilepsy research are ...
Ann Lange was diagnosed with Alzheimer's in 2015, but with the help of clinical trials her disease has not progressed past ...
Lab Essentials products are targeted at the research use only or RUO market and include ... our growing number of Clinical Solutions customers move through later clinical trial phases and ultimately ...
Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...